|
1
|
Habil MR and Hein DW: Effects of dose and
human N-acetyltransferase 1 genetic polymorphism in benzidine
metabolism and genotoxicity. Arch Toxicol. 97:1765–1772. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dietrich HG and Golka K: Bladder tumors
and aromatic amines-historical milestones from Ludwig Rehn to
Wilhelm Hueper. Front Biosci (Elite Ed). 4:279–288. 2012.
View Article : Google Scholar
|
|
3
|
Durgaryan R and Durgaryan N: Chemical
oxidative condensation of benzidine in non-aqueous medium:
Synthesis and investigation of oligomers and polymer with Benzidine
Diimine Units. Polymers (Basel). 14:342021. View Article : Google Scholar
|
|
4
|
Suarez-Torres JD, Orozco CA and
Ciangherotti CE: Applying Bayesian forecasting to predictive
toxicology: The probability of innate carcinogenicity to humans of
colorants synthesized from benzidine. Toxicol Lett. 351:111–134.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kenigsberg AP, Meng X, Ghandour R and
Margulis V: Oncologic outcomes of radical nephroureterectomy (RNU).
Transl Androl Urol. 9:1841–1852. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bayerl F, Meiser P, Donakonda S,
Hirschberger A, Lacher SB, Pedde AM, Hermann CD, Elewaut A, Knolle
M, Ramsauer L, et al: Tumor-derived prostaglandin E2 programs cDC1
dysfunction to impair intratumoral orchestration of anticancer
T-cell responses. Immunity. 56:1341–1358 e11. 2023. View Article : Google Scholar
|
|
7
|
Woolbright BL, Pilbeam CC and Taylor JA
III: Prostaglandin E2 as a therapeutic target in bladder cancer:
From basic science to clinical trials. Prostaglandins Other Lipid
Mediat. 148:1064092020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kissoondoyal A and Crawford DA:
Prostaglandin E2 increases neurite length and the formation of
axonal loops, and regulates cone turning in differentiating NE4C
Cells Via PKA. Cell Mol Neurobiol. 42:1385–1397. 2022. View Article : Google Scholar
|
|
9
|
Chang HH, Young SH, Sinnett-Smith J, Chou
CE, Moro A, Hertzer KM, Hines OJ, Rozengurt E and Eibl G:
Prostaglandin E2 activates the mTORC1 pathway through an
EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human
pancreatic carcinoma cell line PANC-1. Am J Physiol Cell Physiol.
309:C639–C649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao P, Li XG, Yang M, Shao Q, Wang D, Liu
S, Song H, Song B, Zhang Y and Qu X: Hypoxia suppresses the
production of MMP-9 by human monocyte-derived dendritic cells and
requires activation of adenosine receptor A2b via cAMP/PKA
signaling pathway. Mol Immunol. 45:2187–2195. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fang XL, Zhang Q, Xue WW, Tao JH, Zou HD,
Lin QR and Wang YL: Suppression of cAMP/PKA/CREB signaling
ameliorates retinal injury in diabetic retinopathy. Kaohsiung J Med
Sci. 39:916–926. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jeon HG, Jeong IG, Bae J, Lee JW, Won JK,
Paik JH, Kim HH, Lee SE and Lee E: Expression of Ki-67 and COX-2 in
patients with upper urinary tract urothelial carcinoma. Urology.
76:513 e7–12. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Komatsu M, Funakoshi T, Aki T, Unuma K and
Uemura K: Aristolochic acid induces an inflammatory response with
prostaglandin E2 production and apoptosis in NRK-52E proximal
tubular cells. Toxicol Lett. 378:39–50. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liudvytska O and Kolodziejczyk-Czepas J: A
review on rhubarb-derived substances as modulators of
cardiovascular risk factors-A special emphasis on anti-obesity
action. Nutrients. 14:20532022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qin MY, Huang SQ, Zou XQ, Zhong XB, Yang
YF, Zhang YT, Mi ZC, Zhang YS and Huang ZG: Drug-containing serum
of rhubarb-astragalus capsule inhibits the epithelial-mesenchymal
transformation of HK-2 by downregulating TGF-beta1/p38MAPK/Smad2/3
pathway. J Ethnopharmacol. 280:1144142021. View Article : Google Scholar
|
|
16
|
Zou G, Zhang X, Wang L, Li X, Xie T, Zhao
J, Yan J, Wang L, Ye H, Jiao S, et al: Herb-sourced emodin inhibits
angiogenesis of breast cancer by targeting VEGFA transcription.
Theranostics. 10:6839–6853. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dai G, Wang D, Ma S, Hong S, Ding K, Tan X
and Ju W: ACSL4 promotes colorectal cancer and is a potential
therapeutic target of emodin. Phytomedicine. 102:1541492022.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma L, Chen K, Jiang K, Deng G, Jiang P,
Shao J and Yu Z: Emodin inhibits the proliferation and invasion of
bladder cancer cells by downregulatingating Notch1. Int J Clin Exp
Pathol. 10:9452–9459. 2017.
|
|
19
|
Cha TL, Chuang MJ, Tang SH, Wu ST, Sun KH,
Chen TT, Sun GH, Chang SY, Yu CP, Ho JY, et al: Emodin modulates
epigenetic modifications and suppresses bladder carcinoma cell
growth. Mol Carcinog. 54:167–177. 2015. View Article : Google Scholar
|
|
20
|
Luster MI, Tucker AN, Hayes HT, Pung OJ,
Burka T, McMillan R and Eling T: Immunosuppressive effects of
benzidine in mice: Evidence of alterations in arachidonic acid
metabolism. J Immunol. 135:2754–2761. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martin CN, Beland FA, Roth RW and Kadlubar
FF: Covalent binding of benzidine and N-acetylbenzidine to DNA at
the C-8 atom of deoxyguanosine in vivo and in vitro. Cancer Res.
42:2678–2686. 1982.PubMed/NCBI
|
|
22
|
Wong HP, Ho JW, Koo MW, Yu L, Wu WK, Lam
EK, Tai EK, Ko JK, Shin VY, Chu KM and Cho CH: Effects of
adrenaline in human colon adenocarcinoma HT-29 cells. Life Sci.
88:1108–1112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan X, Li J, Long L, Shi T, Liu D, Tan W,
Zhang H, Wu X, Lei X and Wang Z: Design, synthesis and biological
evaluation of N-anthraniloyl tryptamine derivatives as pleiotropic
molecules for the therapy of malignant glioma. Eur J Med Chem.
222:1135642021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Millerick-May ML, Wang L, Rice C and
Rosenman KD: Ongoing risk of bladder cancer among former workers at
the last benzidine manufacturing facility in the USA. Occup Environ
Med. 78:625–631. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Letasiova S, Medve'ova A, Sovcikova A,
Dušinská M, Volkovová K, Mosoiu C and Bartonová A: Bladder cancer,
a review of the environmental risk factors. Environ Health.
11(Suppl 1): S112012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun X, Zhang T, Deng Q, Zhou Q, Sun X, Li
E, Yu D and Zhong C: Benzidine induces epithelial-mesenchymal
transition of human bladder cancer cells through activation of ERK5
pathway. Mol Cells. 41:188–197. 2018.PubMed/NCBI
|
|
27
|
Soria F, Shariat SF, Lerner SP, Fritsche
HM, Rink M, Kassouf W, Spiess PE, Lotan Y, Ye D, Fernández MI, et
al: Epidemiology, diagnosis, preoperative evaluation and prognostic
assessment of upper-tract urothelial carcinoma (UTUC). World J
Urol. 35:379–387. 2017. View Article : Google Scholar
|
|
28
|
Farrow JM, Kern SQ, Gryzinski GM and
Sundaram CP: Nephron-sparing management of upper tract urothelial
carcinoma. Investig Clin Urol. 62:389–398. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang FY, Li RZ, Xu C, Fan XX, Li JX, Meng
WY, Wang XR, Liang TL, Guan XX, Pan HD, et al: Emodin induces
apoptosis and suppresses non-small cell lung cancer growth via
downregulation of sPLA2-IIa. Phytomedicine. 95:1537862022.
View Article : Google Scholar
|
|
30
|
Akbari B, Soltantoyeh T, Shahosseini Z,
Jadidi-Niaragh F, Hadjati J, Brown CE and Mirzaei HR: PGE2-EP2/EP4
signaling elicits mesoCAR T-cell immunosuppression in pancreatic
cancer. Front Immunol. 14:12095722023. View Article : Google Scholar
|
|
31
|
Kurtova AV, Xiao J, Mo Q, Pazhanisamy S,
Krasnow R, Lerner SP, Chen F, Roh TT, Lay E, Ho PL and Chan KS:
Blocking PGE2-induced tumor repopulation abrogates bladder cancer
chemoresistance. Nature. 517:209–213. 2015. View Article : Google Scholar
|
|
32
|
Park MY, Kwon HJ and Sung MK: Evaluation
of aloin and aloe-emodin as anti-inflammatory agents in aloe by
using murine macrophages. Biosci Biotechnol Biochem. 73:828–832.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu H, Song X, Li Y, Ma T, Bai H, Zhao M,
Wang X, Liu L and Gao L: Emodin protects knee joint cartilage in
rats through anti-matrix degradation pathway: An in vitro and in
vivo study. Life Sci. 269:1190012021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang RY and Chen GG: Cigarette smoking,
cyclooxygenase-2 pathway and cancer. Biochim Biophys Acta.
1815:158–169. 2011.
|
|
35
|
Wiktorowska-Owczarek A and Owczarek J: The
effect of hypoxia on PGE2-stimulated cAMP generation in HMEC-1.
Cell Mol Biol Lett. 20:213–221. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ye Y, Wang X, Jeschke U and von Schönfeldt
V: COX-2-PGE2-EPs in gynecological cancers. Arch Gynecol
Obstet. 301:1365–1375. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li T, Hu J, Du S, Chen Y, Wang S and Wu Q:
ERK1/2/COX-2/PGE2 signaling pathway mediates GPR91-dependent VEGF
release in streptozotocin-induced diabetes. Mol Vis. 20:1109–1121.
2014.PubMed/NCBI
|
|
38
|
Steinert D, Kuper C, Bartels H, Beck FX
and Neuhofer W: PGE2 potentiates tonicity-induced COX-2 expression
in renal medullary cells in a positive feedback loop involving
EP2-cAMP-PKA signaling. Am J Physiol Cell Physiol. 296:C75–C87.
2009. View Article : Google Scholar
|
|
39
|
Choudhary S, Kumar A, Kale RK, Raisz LG
and Pilbeam CC: Extracellular calcium induces COX-2 in osteoblasts
via a PKA pathway. Biochem Biophys Res Commun. 322:395–402. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen L, Sooranna SR, Lei K, Kandola M,
Bennett PR, Liang Z, Grammatopoulos D and Johnson MR: Cyclic AMP
increases COX-2 expression via mitogen-activated kinase in human
myometrial cells. J Cell Mol Med. 16:1447–1460. 2012. View Article : Google Scholar
|
